Fort LP Has Boosted Its Twenty First Centy Fox (FOXA) Stake; Shorts at Codexis (CDXS) Raised By 2.84%

January 14, 2018 - By reb123z

Codexis Incorporated (NASDAQ:CDXS) had an increase of 2.84% in short interest. CDXS’s SI was 2.08M shares in January as released by FINRA. Its up 2.84% from 2.02 million shares previously. With 187,000 avg volume, 11 days are for Codexis Incorporated (NASDAQ:CDXS)’s short sellers to cover CDXS’s short positions. The SI to Codexis Incorporated’s float is 7.78%. The stock decreased 0.55% or $0.05 during the last trading session, reaching $9. About 256,784 shares traded or 0.34% up from the average. Codexis, Inc. (NASDAQ:CDXS) has risen 27.19% since January 14, 2017 and is uptrending. It has outperformed by 10.49% the S&P500.

Fort Lp increased Twenty First Centy Fox Inc (FOXA) stake by 831.12% reported in 2017Q3 SEC filing. Fort Lp acquired 244,781 shares as Twenty First Centy Fox Inc (FOXA)’s stock declined 10.68%. The Fort Lp holds 274,233 shares with $7.23 million value, up from 29,452 last quarter. Twenty First Centy Fox Inc now has $67.53B valuation. The stock increased 1.46% or $0.53 during the last trading session, reaching $36.73. About 6.82 million shares traded. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) has declined 2.90% since January 14, 2017 and is downtrending. It has underperformed by 19.60% the S&P500.

Codexis, Inc. discovers, develops, and sells protein catalysts. The company has market cap of $435.12 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening. It currently has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Among 4 analysts covering Codexis (NASDAQ:CDXS), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Codexis had 8 analyst reports since August 12, 2015 according to SRatingsIntel. Zacks upgraded the shares of CDXS in report on Wednesday, August 26 to “Hold” rating. The stock has “Buy” rating by Jefferies on Friday, October 13. The stock has “Buy” rating by H.C. Wainwright on Wednesday, January 6. On Wednesday, August 12 the stock rating was downgraded by Zacks to “Hold”. Ladenburg Thalmann upgraded Codexis, Inc. (NASDAQ:CDXS) on Wednesday, January 4 to “Buy” rating. First Analysis downgraded Codexis, Inc. (NASDAQ:CDXS) on Thursday, January 26 to “Equal-Weight” rating.

Since September 14, 2017, it had 0 buys, and 1 sale for $6.12 million activity. 1.06M shares valued at $6.12M were sold by Vivo Ventures Fund VII – L.P. on Thursday, September 14.

Investors sentiment increased to 2.2 in 2017 Q3. Its up 0.20, from 2 in 2017Q2. It improved, as 2 investors sold Codexis, Inc. shares while 13 reduced holdings. 9 funds opened positions while 24 raised stakes. 25.60 million shares or 11.04% more from 23.06 million shares in 2017Q2 were reported. Envestnet Asset Mngmt Incorporated stated it has 590 shares. Morgan Stanley has 58,438 shares. State Board Of Administration Of Florida Retirement owns 44,892 shares for 0% of their portfolio. Blair William & Il owns 295,877 shares. Jpmorgan Chase And Company owns 60 shares for 0% of their portfolio. Bridgeway Capital Inc holds 270,700 shares. Fincl Bank Of America De has 30,041 shares for 0% of their portfolio. Spark Inv Management Ltd Com stated it has 24,300 shares. Bancshares Of New York Mellon stated it has 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS). 30,000 are held by Perkins Capital Inc. Credit Suisse Ag owns 26,927 shares or 0% of their US portfolio. Parametric Port Assoc Limited Liability Corporation accumulated 11,719 shares. Citigroup Inc reported 0% stake. Telemark Asset Mngmt Ltd Liability Corporation holds 2.8% or 2.05 million shares in its portfolio. Baillie Gifford owns 1.48M shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts